Sign Up to like & get
recommendations!
1
Published in 2022 at "Microscopy Research and Technique"
DOI: 10.1002/jemt.24079
Abstract: Chronic myeloid leukemia (CML) is a myeloproliferative disease and the first line treatment is through the administration of Imatinib, a first generation tyrosine kinase inhibitor. Thrombocytosis and bleeding irregularities are common in CML, however, the…
read more here.
Keywords:
treatment;
imatinib treatment;
microscopy;
platelet morphology ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Cardiovascular Pharmacology"
DOI: 10.1097/fjc.0000000000001344
Abstract: Supplemental Digital Content is Available in the Text. Abstract: Although previous studies support the clinical benefit of imatinib regarding respiratory status in hospitalized patients with COVID-19, potential cardiotoxicity may limit its clinical application. This study…
read more here.
Keywords:
cardiac safety;
imatinib;
safety imatinib;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000014477
Abstract: Rationale: The efficiency and tolerance of long-term adjuvant imatinib treatment for patient who underwent complete resection of a localized recurrent gastrointestinal stromal tumor (GIST) was unknown. Patient concerns: A 45-year-old man underwent complete resection of…
read more here.
Keywords:
imatinib treatment;
treatment;
tumor;
complete resection ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000029411
Abstract: Rationale: Patients with rectal gastrointestinal stromal tumors (GISTs) who achieve a complete response (CR) with imatinib therapy have rarely been reported in the literature. Moreover, no treatment guidelines have been established for rectal GIST patients…
read more here.
Keywords:
stromal tumors;
rectal gastrointestinal;
treatment;
imatinib treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-122219
Abstract: Background: Documented experience on vaccination while on imatinib treatment is missing in children. According to current recommendations for all age groups of immunocompromised individuals inactive vaccines can safely be administered. However, depending on the grade…
read more here.
Keywords:
cml;
imatinib treatment;
treatment;
vaccination ... See more keywords